MYTHIC THERAPEUTICS Trademark

Trademark Overview


On Thursday, July 1, 2021, a trademark application was filed for MYTHIC THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MYTHIC THERAPEUTICS trademark a serial number of 90806162. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, June 20, 2024. This trademark is owned by Mythic Therapeutics, Inc.. The MYTHIC THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for cancer treatment; Pharmaceutical preparations for treatment of multiple sclerosis; Pharmaceutical preparations for use in oncology treatment; Pharmaceutical preparations for treatment of neurological disor...

Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields
mythic therapeutics

General Information


Serial Number90806162
Word MarkMYTHIC THERAPEUTICS
Filing DateThursday, July 1, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, June 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 8, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for cancer treatment; Pharmaceutical preparations for treatment of multiple sclerosis; Pharmaceutical preparations for use in oncology treatment; Pharmaceutical preparations for treatment of neurological disorders; Pharmaceutical preparations for treatment of blood disorders; Pharmaceutical preparations for treatment of oncologic disorders
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 13, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 13, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMythic Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Party NameMythic Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Trademark Events


Event DateEvent Description
Monday, July 5, 2021NEW APPLICATION ENTERED
Monday, September 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 22, 2022ASSIGNED TO EXAMINER
Friday, April 1, 2022NON-FINAL ACTION WRITTEN
Friday, April 1, 2022NON-FINAL ACTION E-MAILED
Friday, April 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 29, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 29, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 30, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 8, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 3, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 15, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 15, 2023SOU EXTENSION 1 FILED
Thursday, June 15, 2023SOU EXTENSION 1 GRANTED
Saturday, June 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 20, 2024SOU TEAS EXTENSION RECEIVED
Friday, June 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 21, 2024SOU EXTENSION 3 FILED
Friday, June 21, 2024SOU EXTENSION 3 GRANTED
Saturday, December 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 7, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 7, 2023SOU EXTENSION 2 FILED
Thursday, December 7, 2023SOU EXTENSION 2 GRANTED